Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiali Hu

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
The Journal of Infection|January 16, 2021
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjectsXiaofen Liu, Yuancheng Chen, Haijing Yang, et al.
Antibodies (Basel, Switzerland)|November 11, 2020
Bringing the Heavy Chain to Light: Creating a Symmetric, Bivalent IgG-Like BispecificAnusuya Ramasubramanian, Rachel Tennyson, Maureen Magnay, et al.
British Journal of Clinical Pharmacology|April 30, 2021
Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysisYi Li, Jianda Lu, Yue Kang, et al.
Antibiotics (Basel, Switzerland)|June 24, 2022
Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose RegimenYaxin Fan, Yi Li, Yuancheng Chen, et al.
Brain : a Journal of Neurology|January 24, 2025
Deep learning analyses of splicing variants identify the link of PCP4 with amyotrophic lateral sclerosisXuelin Tang, Yan Chen, Yongfei Ren, et al.
Head & Neck|December 17, 2018
Novel ANO5 mutation c.1067G>T (p.C356F) identified by whole genome sequencing in a big family with atypical gnathodiaphyseal dysplasiaBinghui Zeng, Junkun Liao, Hanqing Zhang, et al.
Journal of Medicinal Chemistry|December 22, 2016
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine ReceptorsHoward Bregman, Jeffrey R Simard, Kristin L Andrews, et al.
EMBO Molecular Medicine|September 25, 2024
RIG-I is an intracellular checkpoint that limits CD8<sup>+</sup> T-cell antitumour immunityXiaobing Duan, Jiali Hu, Yuncong Zhang, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
The Journal of Infection|January 16, 2021
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjectsXiaofen Liu, Yuancheng Chen, Haijing Yang, et al.
Antibodies (Basel, Switzerland)|November 11, 2020
Bringing the Heavy Chain to Light: Creating a Symmetric, Bivalent IgG-Like BispecificAnusuya Ramasubramanian, Rachel Tennyson, Maureen Magnay, et al.
British Journal of Clinical Pharmacology|April 30, 2021
Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysisYi Li, Jianda Lu, Yue Kang, et al.
Antibiotics (Basel, Switzerland)|June 24, 2022
Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose RegimenYaxin Fan, Yi Li, Yuancheng Chen, et al.
Brain : a Journal of Neurology|January 24, 2025
Deep learning analyses of splicing variants identify the link of PCP4 with amyotrophic lateral sclerosisXuelin Tang, Yan Chen, Yongfei Ren, et al.
Head & Neck|December 17, 2018
Novel ANO5 mutation c.1067G>T (p.C356F) identified by whole genome sequencing in a big family with atypical gnathodiaphyseal dysplasiaBinghui Zeng, Junkun Liao, Hanqing Zhang, et al.
Journal of Medicinal Chemistry|December 22, 2016
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine ReceptorsHoward Bregman, Jeffrey R Simard, Kristin L Andrews, et al.
EMBO Molecular Medicine|September 25, 2024
RIG-I is an intracellular checkpoint that limits CD8<sup>+</sup> T-cell antitumour immunityXiaobing Duan, Jiali Hu, Yuncong Zhang, et al.
Pageof 10